Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

B. G M Durie, S Vincent Rajkumar

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)821
Number of pages1
JournalLeukemia
Volume21
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Thalidomide
Multiple Myeloma
Clinical Trials
Bortezomib

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

@article{606b7c7381b246f8bbeffb506ebfee35,
title = "Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]",
author = "Durie, {B. G M} and Rajkumar, {S Vincent}",
year = "2007",
month = "4",
doi = "10.1038/sj.leu.2404574",
language = "English (US)",
volume = "21",
pages = "821",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma

T2 - A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

AU - Durie, B. G M

AU - Rajkumar, S Vincent

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=33947434523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947434523&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404574

DO - 10.1038/sj.leu.2404574

M3 - Article

AN - SCOPUS:33947434523

VL - 21

SP - 821

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -